Gilead Foundation Commits Over $6.5M in New Grant Funding to Support STEM Education Pathways

Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued stocks to buy and hold for 5 years. On September 25, Gilead Sciences announced that its Gilead Foundation has committed more than $6.5 million in new grant funding to strengthen Science, Technology, Engineering, and Math/STEM education pathways. The funding is part of an ongoing commitment to cultivate a robust talent pipeline from a broad range of backgrounds in the San Francisco Bay Area and beyond.

The investment addresses a critical need, as STEM skills are projected to be essential for 80% of all jobs by the end of the decade, and the US faces a projected shortfall of 1.4 million skilled STEM workers by 2030. The recent grant commitments will support organizations that work to strengthen STEM learning opportunities for students from elementary school through college.

The major allocations include a $1 million grant to the Boys and Girls Clubs of America to support STEM programs for elementary through high school students at eight sites across the Bay Area, Los Angeles, Maryland, Washington DC, New Jersey, and North Carolina. Additionally, a $500,000 grant was awarded to the San Mateo Foster City Education Foundation to boost STEM education for elementary and middle school students in the San Mateo-Foster City School District.

Gilead Sciences Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the US, Europe, and internationally.

While we acknowledge the potential of GILD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.